SGLT2 inhibitors work by helping the kidneys remove excess glucose (sugar) from the bloodstream through urine. This not only helps lower blood sugar levels in people with type 2 diabetes (T2DM) but also appears to reduce stress on the heart and kidneys.
This is a companion discussion topic for the original article at https://patient.info/news-and-features/what-the-new-generic-diabetes-and-heart-medicine-means-for-you-dapagliflozin